Ignyta to Present at the Ladenburg Thalmann 2017 Healthcare Conference
September 18 2017 - 7:00AM
Business Wire
Ignyta, Inc. (Nasdaq:RXDX), a biotechnology company
focused on precision medicine in oncology, announced today that
Jonathan Lim, M.D., its Chairman and Chief Executive Officer, will
make a presentation at the Ladenburg Thalmann 2017 Healthcare
Conference on Tuesday, September 26, 2017, at 2:00 p.m. Eastern
time (11:00 a.m. Pacific time) in New York, NY.
A webcast of the presentation will be available during the
presentation in the Investors section of the company's website at
https://www.ignyta.com/investors/, and will be archived and
available at that site for 14 days.
About Ignyta, Inc.
At Ignyta, we work tirelessly on behalf of patients with
cancer to offer potentially life-saving, precisely targeted
therapeutics (Rx) guided by diagnostic (Dx) tests. Our integrated
Rx/Dx strategy allows us to enter uncharted territory, illuminating
the molecular drivers of cancer and quickly advancing treatments to
address them. This approach embraces even those patients with rare
cancers, who have the highest unmet need and who may otherwise not
have access to effective treatment options. With our pipeline of
potentially first-in-class or best-in-class precision medicines, we
are pursuing the ultimate goal of not just shrinking tumors, but
eradicating cancer relapse and recurrence in precisely defined
patient populations.
For more information, please visit: www.ignyta.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170918005331/en/
Ignyta, Inc.Jacob Chacko, M.D., 858-255-5959CFOjc@ignyta.com
Prometheus Biosciences (NASDAQ:RXDX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Prometheus Biosciences (NASDAQ:RXDX)
Historical Stock Chart
From Sep 2023 to Sep 2024